Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.25B.
ENTERPRISE VALUE (EV)
$1.25B
Hemab Therapeutics Holdings, Inc. Common Stock
Market Cap
$1.34B
Enterprise Value (EV)
$1.25B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG) | $1.34B | $1.25B |
| Omeros Corporation (OMER)vs › | $1.34B | $1.42B |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | $1.30B |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | $1.24B |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | $1.87B |
| Braveheart Bio, Inc. (BRVE)vs › | $1.39B | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | $1.28B |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | $1.00B |
| AnaptysBio, Inc. (ANAB)vs › | $1.41B | $1.55B |
| Omada Health (OMDA)vs › | $1.23B | $1.01B |
Market Cap
$1.34B
Total Debt
$0.00
Cash
$87.97M
Enterprise Value
$1.25B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
